C192153Level 5
Capecitabine/Cisplatin/Pembrolizumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of capecitabine, cisplatin and pembrolizumab that can be used in the treatment of gastric, esophageal and esophagogastric junction cancers.
**Synonyms:** - Capecitabine and Cisplatin (CX) and Pembrolizumab - Capecitabine-Cisplatin-Pembrolizumab - Capecitabine/Cisplatin/Keytruda - Capecitabine/Cisplatin/Pembrolizumab - Capecitabine/Pembrolizumab/Cisplatin - Pembrolizumab/Capecitabine/Cisplatin
GET
/api/v1/systems/nci_thesaurus/nodes/C192153Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.